Supplementary Table 3.
Comparison of the 12 Most Frequently Reported Symptoms and Related Signs During the Course of COVID-19 Between Recovered and Deceased Residents
| Symptoms and Signs∗ | Recovered (Fully or Partially) |
Deceased |
P Value† |
|---|---|---|---|
| (n = 56) | (n = 32) | ||
| Clinical criteria suspected COVID-19 case (WHO) | 52 (92.9) | 32 (100) | .12 |
| Respiratory symptoms and signs | |||
| Cough | 47 (83.9) | 21 (65.6) | .05 |
| Shortness of breath‡ | 29 (51.8) | 23 (71.9) | .07 |
| Highest respiratory rate (/min), median (IQR) | 28 (24–31) | 33 (24–46) | .04 |
| Lowest oxygen saturation on room air (%), median (IQR) | 89 (85–93) | 85 (80–89) | .01 |
| Supplemental oxygen therapy | 20 (69.0) | 17 (73.9) | .70 |
| Lowest oxygen saturation on supplemental oxygen (%), median (IQR) | 91 (88–93) | 85 (79–88) | .02 |
| Rhinorrhea/nasal congestion | 21 (37.5) | 12 (37.5) | 1.00 |
| Sore throat | 13 (23.2) | 5 (15.6) | .40 |
| General symptoms and signs | |||
| Malaise/fatigue | 43 (76.8) | 30 (93.8) | .04 |
| Fever‡ | 39 (69.6) | 28 (87.5) | .06 |
| Highest body temperature (°C), median (IQR) | 38.5 (38.2–38.8) | 38.9 (38.4–39.6) | <.01 |
| Loss of appetite/decreased intake | 32 (57.1) | 32 (100.0) | <.01 |
| Decreased mobility | 24 (42.9) | 30 (93.8) | <.01 |
| Gastrointestinal symptoms | |||
| Diarrhea | 26 (46.4) | 15 (46.9) | .97 |
| Nausea/vomiting | 16 (28.6) | 16 (50.0) | .04 |
| Neurological/behavioral symptoms | |||
| Change in behavior | 12 (21.4) | 10 (31.3) | .31 |
| Confusion/delirium | 8 (14.3) | 10 (31.3) | .06 |
∗
Variables are presented as frequencies, n (%), unless indicated otherwise.
†
χ2-test for categorical variables and Mann-Whitney U test for continuous variables.
‡
Related variables are presented for the group of individuals with the sign/symptom concerned, that is, shortness of breath or fever.